Fundraising Fox
Emulate Bio
Founded 2014 · 73 employees on LinkedIn · 11 known investors
Find your way into Emulate Bio
Sign up to see every warm intro you have to Emulate Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emulate Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.
Founders & leadership
Emulate Bio was founded in 2014 by Donald Ingber and Daniel Levner.
Investors · 11
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: ALS Investment Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: av.vc · Not right? Tell us
How we know: Fourth Realm's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Stray Dog Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Emulate Bio do?
- Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.
- Who founded Emulate Bio?
- Emulate Bio was founded by Donald Ingber, Daniel Levner in 2014.
- Who are Emulate Bio's investors?
- Emulate Bio's investors include +ND Capital, Northpond Ventures, ALS Investment Fund, Alumni Ventures, Alwyn Capital, Fourth Realm, Stray Dog Capital, VegInvest and 3 more.